Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Relative Value
The Relative Value of one
Shandong Weigao Group Medical Polymer Co Ltd
stock under the Base Case scenario is
6.14
HKD.
Compared to the current market price of 5.33 HKD,
Shandong Weigao Group Medical Polymer Co Ltd
is
Undervalued by 13%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Shandong Weigao Group Medical Polymer Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
24.3B HKD | 1.6 | 10.9 | 6.4 | 6.4 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
60B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
8.9T JPY | 9.8 | 35.7 | 25.7 | 30.9 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.6B CHF | 3.8 | 37.3 | 15.4 | 30 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
109.6B DKK | 4 | 30.9 | 14.4 | 17.1 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD | 3.4 | 35.5 | 16.1 | 20.5 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.7 | 29.2 | 13 | 21.1 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.8B CNY | 9.4 | 26 | 23.5 | 23.5 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD | 1.2 | -19.7 | 19.6 | 92.4 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
3.9B CHF | 5 | 20.4 | 13.2 | 18 | |
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.8B USD | 3.2 | 40.4 | 18.4 | 30.7 |